Lung cancer, with non-small cell lung cancer (NSCLC) being the most prevalent form, is the leading cause of cancer-related deaths globally. There are treatment options to combat this cancer, however, they are inneffective and most of the time result in the cancer reaching a persister and tolderance state. So this calls for an important focus on research in this field to save lives and improve the wellbeing of patients. 

NSCLC is commonly known for mutating, and this poses significant challenges in treatment due to its complexity, and the mechanisms that drive tumor progression, as well as resistance to therapy.